Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Current Opinion in Pharmacology
|
May 4, 2007
Potential drug targets within bone morphogenetic protein signaling pathways
Elisabetta Gazzerro, Carlo Minetti
Reviews in Endocrine & Metabolic Disorders
|
October 10, 2006
Bone morphogenetic proteins and their antagonists
Elisabetta Gazzerro, Ernesto Canalis
Expert Review of Endocrinology & Metabolism
|
February 13, 2019
Skeletal actions of insulin-like growth factors
Elisabetta Gazzerro, Ernesto Canalis
Current Neurology and Neuroscience Reports
|
January 22, 2013
Neuromuscular disorders of glycogen metabolism
Elisabetta Gazzerro, Antoni L Andreu, Claudio Bruno
Endocrine Reviews
|
April 18, 2003
Bone morphogenetic proteins, their antagonists, and the skeleton
Ernesto Canalis, Aris N Economides, Elisabetta Gazzerro
Endocrinology
|
May 28, 2005
Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro
Elisabetta Gazzerro, Valerie Deregowski, Sergio Vaira, et al.
The Journal of Biological Chemistry
|
January 13, 2006
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling
Valerie Deregowski, Elisabetta Gazzerro, Leah Priest, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 28, 2006
Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage
Valerie Deregowski, Elisabetta Gazzerro, Leah Priest, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2009
Caveolinopathies: from the biology of caveolin-3 to human diseases
Elisabetta Gazzerro, Federica Sotgia, Claudio Bruno, et al.
Endocrinology
|
September 10, 2003
Notch 1 impairs osteoblastic cell differentiation
Maria Sciaudone, Elisabetta Gazzerro, Leah Priest, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Current Opinion in Pharmacology
|
May 4, 2007
Potential drug targets within bone morphogenetic protein signaling pathways
Elisabetta Gazzerro, Carlo Minetti
Reviews in Endocrine & Metabolic Disorders
|
October 10, 2006
Bone morphogenetic proteins and their antagonists
Elisabetta Gazzerro, Ernesto Canalis
Expert Review of Endocrinology & Metabolism
|
February 13, 2019
Skeletal actions of insulin-like growth factors
Elisabetta Gazzerro, Ernesto Canalis
Current Neurology and Neuroscience Reports
|
January 22, 2013
Neuromuscular disorders of glycogen metabolism
Elisabetta Gazzerro, Antoni L Andreu, Claudio Bruno
Endocrine Reviews
|
April 18, 2003
Bone morphogenetic proteins, their antagonists, and the skeleton
Ernesto Canalis, Aris N Economides, Elisabetta Gazzerro
Endocrinology
|
May 28, 2005
Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro
Elisabetta Gazzerro, Valerie Deregowski, Sergio Vaira, et al.
The Journal of Biological Chemistry
|
January 13, 2006
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling
Valerie Deregowski, Elisabetta Gazzerro, Leah Priest, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 28, 2006
Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage
Valerie Deregowski, Elisabetta Gazzerro, Leah Priest, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2009
Caveolinopathies: from the biology of caveolin-3 to human diseases
Elisabetta Gazzerro, Federica Sotgia, Claudio Bruno, et al.
Endocrinology
|
September 10, 2003
Notch 1 impairs osteoblastic cell differentiation
Maria Sciaudone, Elisabetta Gazzerro, Leah Priest, et al.
Page
of 5